AAAAAA
Results:
1-14
|
Results: 14
Authors:
Matzdorff, AC
Kuhnel, G
Kemkes-Matthes, B
Voss, R
Citation: Ac. Matzdorff et al., Comparison of GP IIB/IIIA inhibitors and their activity as measured by aggregometry, flow cytometry, single platelet counting, and the rapid plateletfunction analyzer, J THROMB TH, 12(2), 2001, pp. 129-139
Authors:
Kemkes-Matthes, B
Citation: B. Kemkes-matthes, Changes in the coagulation system during pregnancy, Z KARDIOL, 90, 2001, pp. 45-48
Authors:
Kemkes-Matthes, B
Matthes, KJ
Citation: B. Kemkes-matthes et Kj. Matthes, Protein Z, SEM THROMB, 27(5), 2001, pp. 551-556
Authors:
Kemkes-Matthes, B
Citation: B. Kemkes-matthes, Diagnostic measures for evaluation of thrombophilia, ZBL CHIR, 126(6), 2001, pp. 433-437
Authors:
Holschermann, H
Hilgendorff, A
Kemkes-Matthes, B
Schonburg, M
Bauer, EP
Tillmanns, H
Haberbosch, W
Citation: H. Holschermann et al., Simvastatin attenuates vascular hypercoagulability in cardiac transplant recipients, TRANSPLANT, 69(9), 2000, pp. 1830-1836
Authors:
Matzdorff, AC
Kuhnel, G
Kemkes-Matthes, B
Pralle, H
Voss, R
Fareed, J
Citation: Ac. Matzdorff et al., Effect of glycoprotein IIb/IIIa inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro, J LA CL MED, 135(3), 2000, pp. 247-255
Authors:
Schmidt, KG
von Ruckmann, A
Kemkes-Matthes, B
Hammes, HP
Citation: Kg. Schmidt et al., Ocular pulse amplitude in diabetes mellitus, BR J OPHTH, 84(11), 2000, pp. 1282-1284
Authors:
Matzdorff, A
Kemkes-Matthes, B
Pralle, H
Citation: A. Matzdorff et al., Microparticles and reticulated platelets in Wiskott-Aldrich syndrome patients, BR J HAEM, 109(3), 2000, pp. 673-673
Authors:
Stolz, E
Kemkes-Matthes, B
Potzsch, B
Hahn, M
Kraus, J
Wirbartz, A
Kaps, M
Citation: E. Stolz et al., Screening for thrombophilic risk factors among 25 German patients with cerebral venous thrombosis, ACT NEUR SC, 102(1), 2000, pp. 31-36
Authors:
Keller, C
Matzdorff, AC
Kemkes-Matthes, B
Citation: C. Keller et al., Pharmacology of warfarin and clinical implications, SEM THROMB, 25(1), 1999, pp. 13-16
Authors:
Greinacher, A
Volpel, H
Janssens, U
Hach-Wunderle, V
Kemkes-Matthes, B
Eichler, P
Mueller-Velten, HG
Potzsch, B
Citation: A. Greinacher et al., Recombinant hirudin (Lepirndin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia - A prospective study, CIRCULATION, 99(1), 1999, pp. 73-80
Authors:
Greinacher, A
Janssens, U
Berg, G
Bock, M
Kwasny, H
Kemkes-Matthes, B
Eichler, P
Volpel, H
Potzsch, B
Luz, M
Citation: A. Greinacher et al., Lepirudin (recombinant hirudin) for parenteral anticoagulation in patientswith heparin-induced thrombocytopenia, CIRCULATION, 100(6), 1999, pp. 587-593
Authors:
Matzdorff, AC
Berchner, D
Kuhnel, G
Kemkes-Matthes, B
Pralle, H
Voss, R
Citation: Ac. Matzdorff et al., Relative and absolute changes of activated platelets, microparticles and platelet aggregates after activation in vitro, HAEMOSTASIS, 28(6), 1998, pp. 277-288
Authors:
Matzdorff, AC
Kemkes-Matthes, B
Pralle, H
Citation: Ac. Matzdorff et al., Reactivity of platelets from healthy individuals and from patients with hematologic diseases following incubation with pegylated recombinant human megakaryocyte growth and development factor in vitro, HAEMOSTASIS, 28(1), 1998, pp. 37-44
Risultati:
1-14
|